DEFENDER trial: dapagliflozin for critically ill patients with acute organ dysfunction-implications for clinicians.

IF 4.8 2区医学 Q1 TRANSPLANTATION

Nephrology Dialysis Transplantation Pub Date : 2025-06-30 DOI:10.1093/ndt/gfaf013

Jolanta Malyszko, Sophie de Seigneux, Vincenzo Cantaluppi, Stanislas Faguer, Joana Gameiro, Jose Antonio Lopes, Ana B Sanz, Turgay Saritas, Nicholas M Selby, Marlies Ostermann

引用次数: 0

查看原文本刊更多论文

DEFENDER试验：达格列净用于急性器官功能障碍的危重患者-对临床医生的影响。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Nephrology Dialysis Transplantation 医学-泌尿学与肾脏学

CiteScore

10.10

自引率

4.90%

发文量

1431

审稿时长

1.7 months

期刊介绍： Nephrology Dialysis Transplantation (ndt) is the leading nephrology journal in Europe and renowned worldwide, devoted to original clinical and laboratory research in nephrology, dialysis and transplantation. ndt is an official journal of the [ERA-EDTA](http://www.era-edta.org/) (European Renal Association-European Dialysis and Transplant Association). Published monthly, the journal provides an essential resource for researchers and clinicians throughout the world. All research articles in this journal have undergone peer review. Print ISSN: 0931-0509.